Daniel Cowley, DO
Adult Reconstructive Orthopaedic Surgery · Grants Pass, ORNPI 1407149487
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Medical Device Business Services, Inc. at 58.2% of the total. Reporting peaked in 2023 at $6,914 and has fallen 97.3% since, to $187 in 2025.
Across 79 payments — averaging $157.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$7K
- Johnson & Johnson$4K
- Stryker$745
- Pacira Pharmaceuticals Incorporated$126
- DJO, LLC$28
What the payments were for
- Consulting fees$5,23142%
- Travel & lodging$3,22426%
- Food & beverage$3,96532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 25 | $7,227 |
| Johnson & Johnson(2 entities) | 45 | $4,295 |
| Stryker | 6 | $745 |
| Pacira Pharmaceuticals Incorporated | 2 | $126 |
| DJO, LLC | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$1,213
- Velys$676
- MAKO$601
- CORAIL$398
- PINNACLE$398
- RECLAIM$398
- GRIPTION TF$398
- EXPAREL$110
- JOINTPOINT$105
How this compares
$12,420 in reported general payments places this provider in the 65th percentile of 20 adult reconstructive orthopaedic surgery providers in Oregon.
See all adult reconstructive orthopaedic surgery providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 74 | $1,303 |
| Ondansetron OdtOndansetron | 47 | $578 |
| Methocarbamol | 54 | $551 |
| Pregabalin | 61 | $542 |
| Omeprazole | 70 | $307 |
| Oxycodone Hcl | 55 | $287 |
| Amoxicillin | 151 | $215 |
| Cephalexin | 11 | $211 |
| Tramadol Hcl | 95 | $207 |
| Meloxicam | 43 | $124 |
| Ondansetron Hcl | 27 | $111 |
| Mupirocin | 13 | $88 |
| Clindamycin Hcl | 27 | $35 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Grants Pass
- James VanhorneGrants Pass$42K
- Ryland KaganPortland$154K
- Thomas HuffPortland$95K
- Gustav FischerPortland$24K
- James HoMedford$15K
- Lily WoodPortland$14K
- Jessica PhillipsBeaverton$12K
- Mary SkrzynskiBend$10K
- Mark MildrenEugene$10K
- Gerald AggreyEugene$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.